Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapy

DOI: 10.1080/2162402X.2016.1213934

Keywords: Heterogeneity, lung cancer, PD-1, PD-L1, PD-L2

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text